ONB
TAK icon

Old National Bancorp’s Takeda Pharmaceutical TAK Stock Holding History

Old National Bancorp’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,883
Closed -$206K – 614
2025
Q1 		$206K Sell
13,883
-11,374
-45% -$159K 0.01% 494
2024
Q4 		$334K Sell
25,257
-4,492
-15% -$61.7K 0.01% 487
2024
Q3 		$423K Sell
29,749
-1,512
-5% -$21.4K 0.01% 420
2024
Q2 		$405K Buy
31,261
+2,297
+8% +$30.4K 0.01% 405
2024
Q1 		$402K Buy
28,964
+2,033
+8% +$29.6K 0.01% 412
2023
Q4 		$384K Sell
26,931
-1,343
-5% -$19.1K 0.01% 421
2023
Q3 		$437K Buy
28,274
+291
+1% +$4.5K 0.01% 415
2023
Q2 		$440K Buy
27,983
+6,783
+32% +$111K 0.01% 434
2023
Q1 		$349K Buy
21,200
+1,874
+10% +$29.9K 0.01% 492
2022
Q4 		$301K Sell
19,326
-509
-3% -$7.11K 0.01% 541
2022
Q3 		$257K Buy
19,835
+7,480
+61% +$104K 0.01% 571
2022
Q2 		$173K Buy
12,355
+527
+4% +$7.52K 0.01% 612
2022
Q1 		$169K Sell
11,828
-52
-0.4% -$764 0.01% 515
2021
Q4 		$162K Sell
11,880
-467
-4% -$6.55K 0.01% 509
2021
Q3 		$202K Hold
12,347
– – 0.01% 511
2021
Q2 		$208K Buy
+12,347
New +$210K 0.01% 504

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Old National Bancorp's TAK Position: Q2 2025 in Review

Old National Bancorp sold out of Takeda Pharmaceutical (TAK) in Q2 2025, closing a stake of 13,883 shares — an estimated $206K sold.

Old National Bancorp first reported a position in TAK in Q2 2021 and held it in 16 quarters. The position peaked at $440K in Q2 2023. 317 funds tracked by Wall St. Rank hold TAK as of Q2 2025.

  • Old National Bancorp reported no remaining Takeda Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Old National Bancorp sold 13,883 Takeda Pharmaceutical shares in Q2 2025, an estimated $206K.
  • Old National Bancorp first reported a position in Takeda Pharmaceutical in Q2 2021 and held it in 16 quarters.
  • Old National Bancorp's Takeda Pharmaceutical position peaked at $440K in Q2 2023.
  • 317 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2025.

Based on Old National Bancorp's 13F filing for Q2 2025, filed 22 Jul 2025.